Abstract
Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained via expanded access protocol. With focused research and drug development efforts, the poor outcomes associated with these infections may be mitigated.
| Original language | English (US) |
|---|---|
| Article number | e00924-21 |
| Journal | Antimicrobial agents and chemotherapy |
| Volume | 65 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2021 |
Keywords
- Acinetobacter baumanii
- Antibiotic resistance
- Antimicrobial agents
- Beta-lactamases
- Beta-lactams
- Durlobactam
- Gram-negative bacteria
- Gram-negative resistance
- Nosocomial infections
- Novel antibiotics
- Sulbactam-durlobactam
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Extensively drug-resistant acinetobacter baumannii nosocomial pneumonia successfully treated with a novel antibiotic combination'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS